Beggar-Thy-Neighbor Medicine: Wall Street Journal Op-Ed
In an editorial about specialty drug prices, the Wall Street Journal writes: “To understand how ObamaCare is already bending the future of U.S. medical progress, consult the furor over specialty drug...
View ArticleClik here to view.
The Eyes Have It According to Recent VC Funding Patterns
A recent Wall Street Journal analysis of venture capital investment trends since 1999 reveals which human body parts are experiencing the biggest rise in funding. The report was based on data from...
View ArticleClik here to view.
European Union Lags Well Behind the U.S. in Innovation
There are many different explanations for the euro crisis: poor fiscal management, loose banking regulation, etc…But one major contributor to Europe’s problems that continues to hold back economies...
View ArticleLa Belle Ville—Making the Most of this Year’s World Congress
While you are attending this year’s BIO 2015 World Congress, let The Wall Street Journal enrich your experience by showing you the best places to eat, shop and stay in La Belle Ville—the beautiful...
View ArticleDr. Scott Gottlieb: A Clintonian Misdirection on Drug Prices
Today’s Wall Street Journal contains an excellent op-ed by Dr. Scott Gottlieb, a physician and resident fellow at the American Enterprise Institute. Dr. Gottlieb takes aim at the recent proposal...
View ArticleClik here to view.
A Clue to Growing Food on Mars Someday
With a Rotten Tomatoes score of 93%, the Martian has become a box office hit, grossing over $571 million worldwide. During a manned mission to Mars, Astronaut Mark Watney (Matt Damon) is presumed dead...
View ArticleClik here to view.
“How to Make Medicine More Expensive.”
That’s the appropriate title of a Wall Street Journal editorial released earlier this week, which opines on a trend in state capitals to further regulate pharmaceutical manufacturers. The center of...
View ArticleClik here to view.
ICYMI: Drug Development is Complicated. Let’s Start with the Facts.
Here’s a fact you might not have known: 90% of drug development programs fail. Yet a recent paper published by JAMA Internal Medicine attempts to tell a different story – one that neglects to consider...
View ArticleClik here to view.
Gene Editing Is A Continuum of Plant Breeding
At the end of March, the U.S. Department of Agriculture, the government agency regulating genetically engineered plants, clarified that under its biotechnology regulations the agency “does not regulate...
View ArticleClik here to view.
Recombinetics’ Animal Gene Editing Could Transform the Beef Industry
Brazil may not be first in the world in beef production, but the South American country could soon be the first to raise Angus cattle in a warmer climate. In a video for the Wall Street Journal,...
View Article
